A Andalusian public health research group has received a donation of 10,000 euros from the Opped the Cancer Foundation, an entity at the national level that promotes and supports research projects and collaborates with these researchers for six years.
The group, led by scientist Benoit Gauthier, develops his work at the Andalusian Center for Molecular Biology and Regenerative Medicine, Cabimer.Among its lines of research, the study of the relationship between type 2 diabetes (DT2) and the increased risk of developing cancer, a work they have been doing for some years and has generated several publications in international scientific journals.
This study began after the publication of epidemiological evidence that indicated a greater incidence of tumors (mainly pancreatic and liver) between patients with DT2 which highlighted the need to identify the underlying connection between these two diseases.The priority objective is to characterize the cell and molecular changes associated with high levels of insulin and/or glucose in the body, so that the clinical application of the results obtained from this research allows on the one hand to stop the development of DT2 with theconsequent decline in cancer risk, while we can identify the routes involved in malignancy.
The study of the association between type 2 diabetes and cancer is of great importance given the epidemic proportions to which diabetes is reaching, especially type 2, with more than 400 million worldwide affected, which will be 642 million in 2040.Spain affects 12% of the adult population (one in eight), with about 300,000 new cases a year.
With this donation, the Foundation win cancer continues with its support for oncological research and this specific project.The Mission of the Foundation to win cancer is to raise private funds to help finance research projects selected by a committee of scientific reputics and continue advancing in the core of cancer, which already affects one in two Spaniards.
In Cabimer, overcome cancer, in addition to this project by Professor Gauthier, it is supporting the work coordinated by Andrés Aguilera, scientific director of the center, based on selective therapy aimed at the breast and prostate cancer cell genome.Overcoming cancer also supports other projects in various Spanish research centers to deal with lung, pancreas, colon and leukemia cancers.
